ArticleCells2020

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.

Yassine Belloum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.